The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3tJEkeR
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» PharmEasy acquires Aknamed in $180-$190 million stock deal
https://ift.tt/eA8V8J
No comments:
Post a Comment